Streetbeat News

Analyst Ratings

AG

First Majestic Silver (NYSE:AG) reported Q3 adjusted losses of $(0.04) per share, missing the analyst consensus estimate of $0.02 by 300 percent. The company also reported quarterly sales of $133.20 million, missing the analyst consensus estimate of $134.00 million by 0.60 percent.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:13 am

TTMI

Needham analyst James Ricchiuti maintains a Buy rating on TTM Technologies (NASDAQ:TTMI) and raises the price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:13 am

GNRC

Stifel analyst Stephen Gengaro has upgraded Generac Hldgs (NYSE:GNRC) from Hold to Buy and raised the price target from $130 to $135.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:12 am

CCLD

CareCloud (NASDAQ:CCLD) reported Q3 earnings of $0.01 per share, beating the analyst consensus estimate of $(0.33) by 103.03%. However, the company's quarterly sales of $29.30 million missed the analyst consensus estimate of $30.42 million by 3.68%. This represents a 95.24% decrease in earnings and a 13.12% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:12 am

ABNB

Needham analyst Bernie McTernan has maintained a 'Buy' rating on Airbnb (NASDAQ:ABNB) but lowered the price target from $160 to $150.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:10 am

CRTO

Criteo (NASDAQ:CRTO) reported Q3 adjusted earnings of $0.71 per share, beating the analyst consensus estimate of $0.61 by 16.39%. This is a 33.96% increase from the same period last year. The company also reported quarterly sales of $469.00 million, beating the analyst consensus estimate of $239.57 million by 95.77%, a 119.80% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:09 am

OKYO

HC Wainwright & Co. analyst Yi Chen has initiated coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:07 am

VIRT

Virtu Finl (NASDAQ:VIRT) reported Q3 adjusted earnings of $0.45 per share, beating the analyst consensus estimate of $0.41 by 9.76%. However, this is a 26.23% decrease from the same period last year. The company also reported quarterly sales of $298.01 million, beating the analyst consensus estimate of $287.78 million by 3.55%, but this is a 10.01% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:06 am

EYPT

HC Wainwright & Co. analyst Yi Chen maintains a 'Buy' rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) but has lowered the price target from $27 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:06 am

CROX

Crocs (NASDAQ:CROX) reported Q3 adjusted earnings of $3.25 per share, beating the analyst consensus estimate of $3.10 by 4.84%. This is a 9.43% increase from the same period last year. The company also reported quarterly sales of $1.04 billion, beating the analyst consensus estimate of $1.03 billion by 1.46%, a 6.08% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:06 am